Financial relationships between board‐certified neurologists and the pharmaceutical industry in Japan

This study evaluated the size and fraction of non‐research compensation to Japanese board‐certified neurologists from the pharmaceutical industry between 2016 and 2020. We found that more than US$45 million were made to 59.2% of all neurologists over the five years. There was an increasing trend in...

Full description

Saved in:
Bibliographic Details
Published inClinical and translational discovery Vol. 4; no. 1
Main Authors Murayama, Anju, Higuchi, Kenichi, Senoo, Yuki
Format Journal Article
LanguageEnglish
Published Birtinya John Wiley & Sons, Inc 01.02.2024
Wiley
Subjects
Alzheimer's disease
conflicts of interest
Dementia
ethics
health policy
Meals
Pharmaceutical industry
physician payment
profession
professionalism
Trends
United States > US
Japan
Online AccessGet full text

Cover

More Information
Summary:This study evaluated the size and fraction of non‐research compensation to Japanese board‐certified neurologists from the pharmaceutical industry between 2016 and 2020. We found that more than US$45 million were made to 59.2% of all neurologists over the five years. There was an increasing trend in the payments to the neurologists over time.
ISSN:2768-0622
2768-0622
DOI:10.1002/ctd2.268